Marstacimab in the treatment of patients with hemophilia A and B
Journal of Transfusion Medicine and Hemostasis · 27.03.2026 · 19
DOI: 10.5603/jtmh.108547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Transfusion Medicine and Hemostasis, online erschienen am 27.03.2026. Verfasst von Jerzy Windyga und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Windyga, J., Chojnowski, K., Łaguna, P., Łętowska, M., Młynarski, W., Mital, A., Treliński, J. T., Urasiński, T., & Podolak-Dawidziak, M. (2026). Marstacimab in the treatment of patients with hemophilia A and B. Journal of Transfusion Medicine and Hemostasis, 19(0). https://doi.org/10.5603/jtmh.108547
Vancouver
Windyga J, Chojnowski K, Łaguna P, Łętowska M, Młynarski W, Mital A, et al. Marstacimab in the treatment of patients with hemophilia A and B. Journal of Transfusion Medicine and Hemostasis. 2026;19(0). doi:10.5603/jtmh.108547
BibTeX
@article{Windyga2026,
author = {Windyga, Jerzy and Chojnowski, Krzysztof and Łaguna, Paweł and Łętowska, Magdalena and Młynarski, Wojciech and Mital, Andrzej and Treliński, Jacek Treliński and Urasiński, Tomasz and Podolak-Dawidziak, Maria},
title = {Marstacimab in the treatment of patients with hemophilia A and B},
journal = {Journal of Transfusion Medicine and Hemostasis},
year = {2026},
volume = {19},
number = {0},
doi = {10.5603/jtmh.108547}
}
EUVIMED